PET study of the effects of valproate on dopamine D2 receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania

American Journal of Psychiatry

Volumn 159, Issue 10, 2002, Pages 1718-1723

  Yatham, Lakshmi N ^a   Liddle, Peter F ^a   Lam, Raymond W ^a   Shiah, I Shin ^a   Lane, Carol ^a   Stoessl, A Jon ^a   Sossi, Vesna ^a   Ruth, Thomas J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CARBON 11; DOPAMINE 2 RECEPTOR; LORAZEPAM; MOOD STABILIZER; NEUROLEPTIC AGENT; OXAZEPAM; PSYCHOTROPIC AGENT; RACLOPRIDE; TEMAZEPAM; TRANQUILIZER; UNCLASSIFIED DRUG; VALPROATE SEMISODIUM;

ADULT; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; HUMAN; MALE; MANIA; MONOTHERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; RECEPTOR AFFINITY; RECEPTOR DENSITY; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTICONVULSANTS; BIPOLAR DISORDER; BRAIN; CEREBELLUM; CORPUS STRIATUM; FEMALE; HUMANS; MALE; MIDDLE AGED; RACLOPRIDE; RECEPTORS, DOPAMINE D2; TOMOGRAPHY, EMISSION-COMPUTED; VALPROIC ACID;

EID: 0036787456     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.159.10.1718     Document Type: Article

References (30)

1. Chou JC: Recent advances in treatment of acute mania. J Clin Psychopharmacol 1991; 11:3-21
2. Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KNR, Daniel DG, Petty F, Centorrino F, Wang R, Grundy SL, Greaney MG, Jacobs TG, David SR, Toma V (Olanzapine HGEH Study Group): Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry 1999; 156:702-709
3. Yatham LN: Safety and efficacy of risperidone as combination therapy for the manic phase of bipolar disorder: preliminary findings of a randomized double blind study (RIS-INT-46) (abstract). Int J Neuropsychopharmacology 2000; 3(suppl 1):S142
4. Keck PE Jr, Mendlwicz J, Calabrese JR, Fawcett J, Suppes T, Vestergaard PA, Carbonell C: A review of randomized, controlled clinical trials in acute mania. J Affect Disord 2000; 59(suppl 1): S31-S37
5. Nolen WA: Dopamine and mania: the effects of trans- and cis-clopenthixol in a double-blind pilot study. J Affect Disord 1983; 5:91-96
6. Cookson JC, Silverstone T, Rees L: Plasma prolactin and growth hormone levels in manic patients treated with pimozide. Br J Psychiatry 1982; 140:274-279
7. Pert A, Rosenblatt JE, Sivit C, Pert CB, Bunney WE Jr: Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity. Science 1978; 201:171-173
8. 11C]raclopride. Arch Gen Psychiatry 1990; 47:213-219
9. 2 dopamine receptors in drug-naive schizophrenics. Science 1986; 234:1558-1563
10. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB: Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 1996; 93:9235-9240
11. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D: Schizophrenia is associated with elevated amphetamine-induced synaptic clopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 1997; 94:2569-2574
12. 2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder. Arch Gen Psychiatry 1995; 52:471-477
13. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG (Depakote Mania Study Group): Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994; 271:918-924; correction, 271:1830
14. Waldmeier PC: Is there a common denominator for the antimanic effect of lithium and anticonvulsants? Pharmacopsychiatry 1987; 20:37-47
15. Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133:429-435
16. 18F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first episode nonpsychotic mania: effects of treatment with divalproex sodium. Am J Psychiatry 2002; 159:768-774
17. Woods RP, Cherry SR, Mazziotta JC: Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr 1992; 16:620-633
18. 11C]raclopride studies. J Cereb Blood Flow Metab 1996; 16:42-52
19. Lammertsma AA, Hume SP: Simplified reference tissue model for PET receptor studies. Neuroimage 1996; 4:153-158
20. Sossi V, Holden JE, Chan G, Krzywinski M, Stoessl AJ, Ruth TJ: Analysis of four dopaminergic tracers kinetics using two different tissue input function methods. J Cereb Blood Flow Metab 2000; 20:653-660
21. Volkow ND, Gur RC, Wang G-J, Fowler JS, Moberg PJ, Ding Y-S, Hitzemann R, Smith G, Logan J: Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry 1998; 155: 344-349
22. 2 receptor binding characteristics in vivo. Am J Psychiatry 1998; 155:768-773
23. 2-like receptors in the human brain. Am J Psychiatry 2001; 158:308-311
24. 2 receptor measured by PET. Life Sci 2001; 69:1079-1084
25. 11C-raclopride and positron emission tomography. J Neurosci 1992; 12:3773-3780
26. 2 receptor binding characteristics in man-a positron emission tomography study. Psychopharmacology (Berl) 1997; 132:361-365
27. Laruelle M, Abi-Dargham A, van Dyck CH, Rosenblatt W, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Charney DS, Hoffer PB, Kung HF: SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med 1995; 36:1182-1190
28. 11C]raclopride binding with continuous infusion. J Cereb Blood Flow Metab 1997; 17: 437-447
29. 2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA 2000; 97:8104-8109
30. Anand A, Verhoeff P, Seneca N, Zoghbi SS, Seibyl JP, Charney DS, Innis RB: Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. Am J Psychiatry 2000; 157:1108-1114